Can NMR solve some significant challenges in metabolomics?

The field of metabolomics continues to witness rapid growth driven by fundamental studies, methods development, and applications in a number of disciplines that include biomedical science, plant and nutrition sciences, drug development, energy and environmental sciences, toxicology, etc. NMR spectroscopy is one of the two most widely used analytical platforms in the metabolomics field, along with mass spectrometry (MS). NMR's excellent reproducibility and quantitative accuracy, its ability to identify structures of unknown metabolites, its capacity to generate metabolite profiles using intact bio-specimens with no need for separation, and its capabilities for tracing metabolic pathways using isotope labeled substrates offer unique strengths for metabolomics applications. However, NMR's limited sensitivity and resolution continue to pose a major challenge and have restricted both the number and the quantitative accuracy of metabolites analyzed by NMR. Further, the analysis of highly complex biological samples has increased the demand for new methods with improved detection, better unknown identification, and more accurate quantitation of larger numbers of metabolites. Recent efforts have contributed significant improvements in these areas, and have thereby enhanced the pool of routinely quantifiable metabolites. Additionally, efforts focused on combining NMR and MS promise opportunities to exploit the combined strength of the two analytical platforms for direct comparison of the metabolite data, unknown identification and reliable biomarker discovery that continue to challenge the metabolomics field. This article presents our perspectives on the emerging trends in NMR-based metabolomics and NMR's continuing role in the field with an emphasis on recent and ongoing research from our laboratory.

[1]  Daniel Raftery,et al.  Expanding the Limits of Human Blood Metabolite Quantitation Using NMR Spectroscopy , 2014, Analytical chemistry.

[2]  Eduard Y Chekmenev,et al.  PASADENA hyperpolarized 13C phospholactate. , 2012, Journal of the American Chemical Society.

[3]  John Kurhanewicz,et al.  Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. , 2011, Neoplasia.

[4]  Kazuo Shinozaki,et al.  Systematic NMR Analysis of Stable Isotope Labeled Metabolite Mixtures in Plant and Animal Systems: Coarse Grained Views of Metabolic Pathways , 2008, PloS one.

[5]  R. B. Kingsley,et al.  WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. , 1994, Journal of magnetic resonance. Series B.

[6]  Robert S Plumb,et al.  1H NMR and UPLC-MS(E) statistical heterospectroscopy: characterization of drug metabolites (xenometabolome) in epidemiological studies. , 2008, Analytical chemistry.

[7]  Rafael Brüschweiler,et al.  Carbon backbone topology of the metabolome of a cell. , 2012, Journal of the American Chemical Society.

[8]  Brian D Ross,et al.  Towards hyperpolarized (13)C-succinate imaging of brain cancer. , 2007, Journal of magnetic resonance.

[9]  J. Choi,et al.  HR-MAS MR Spectroscopy of Breast Cancer Tissue Obtained with Core Needle Biopsy: Correlation with Prognostic Factors , 2012, PloS one.

[10]  Kathleen A Stringer,et al.  The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses. , 2011, American journal of respiratory and critical care medicine.

[11]  Ivano Bertini,et al.  Evidence of different metabolic phenotypes in humans , 2008, Proceedings of the National Academy of Sciences.

[12]  D. Gauguier,et al.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.

[13]  Daniel Raftery,et al.  Use of EDTA to minimize ionic strength dependent frequency shifts in the 1H NMR spectra of urine , 2008, Metabolomics.

[14]  Christian Ludwig,et al.  Optimizing the signal enhancement in cryogenic ex situ DNP-NMR spectroscopy. , 2008, Journal of the American Chemical Society.

[15]  Daniel Raftery,et al.  Advances in NMR-based biofluid analysis and metabolite profiling. , 2010, The Analyst.

[16]  John C Lindon,et al.  Statistical spectroscopic tools for biomarker discovery and systems medicine. , 2013, Analytical chemistry.

[17]  Mark R Viant,et al.  Optimized metabolite extraction from blood serum for 1H nuclear magnetic resonance spectroscopy. , 2008, Analytical biochemistry.

[18]  Daniel Raftery,et al.  New Solenoidal Microcoil NMR Probe Using Zero-Susceptibility Wire. , 2010, Concepts in magnetic resonance. Part B, Magnetic resonance engineering.

[19]  Luigi Atzori,et al.  Metabolomics as a tool for cardiac research , 2011, Nature Reviews Cardiology.

[20]  Thomas M. O’Connell,et al.  The application of micro-coil NMR probe technology to metabolomics of urine and serum , 2011, Journal of biomolecular NMR.

[21]  A. Lane,et al.  Stable isotope-resolved metabolomics and applications for drug development. , 2012, Pharmacology & therapeutics.

[22]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[23]  Vitor Sousa,et al.  Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. , 2011, Journal of proteome research.

[24]  Wayne R Matson,et al.  Structural characterization of plasma metabolites detected via LC-electrochemical coulometric array using LC-UV fractionation, MS, and NMR. , 2012, Analytical chemistry.

[25]  Daniel Raftery,et al.  13C-formylation for improved nuclear magnetic resonance profiling of amino metabolites in biofluids. , 2010, Analytical chemistry.

[26]  Thomas Szyperski,et al.  Standard operating procedure for metabonomics studies of blood serum and plasma samples using a 1H‐NMR micro‐flow probe , 2009, Magnetic resonance in chemistry : MRC.

[27]  Rafael Brüschweiler,et al.  Multidimensional approaches to NMR-based metabolomics. , 2014, Analytical chemistry.

[28]  J. Nicholson,et al.  1H NMR studies on protein binding of histidine, tyrosine and phenylalanine in blood plasma , 1989, NMR in biomedicine.

[29]  Daniel Raftery,et al.  Early detection of recurrent breast cancer using metabolite profiling. , 2010 .

[30]  Daniel Raftery,et al.  Use of selective TOCSY NMR experiments for quantifying minor components in complex mixtures: application to the metabonomics of amino acids in honey. , 2005, Analytical chemistry.

[31]  John L Markley,et al.  Method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H-13C NMR spectra. , 2007, Analytical chemistry.

[32]  Jian Zhang,et al.  Metabolomics study of esophageal adenocarcinoma. , 2011, The Journal of thoracic and cardiovascular surgery.

[33]  Daniel Raftery,et al.  R: A quantitative measure of NMR signal receiving efficiency. , 2009, Journal of magnetic resonance.

[34]  Manfred Spraul,et al.  Virtual chromatographic resolution enhancement in cryoflow LC-NMR experiments via statistical total correlation spectroscopy. , 2007, Analytical chemistry.

[35]  Daniel Raftery,et al.  Susceptibility-matched plugs for microcoil NMR probes. , 2010, Journal of magnetic resonance.

[36]  Stephen E. Stein,et al.  Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. , 2013, Analytical chemistry.

[37]  Daniel Raftery,et al.  Class selection of amino acid metabolites in body fluids using chemical derivatization and their enhanced 13C NMR , 2007, Proceedings of the National Academy of Sciences.

[38]  Zerihun T. Dame,et al.  The Human Urine Metabolome , 2013, PloS one.

[39]  Daniel Raftery,et al.  Signal enhancement in HPLC/microcoil NMR using automated column trapping. , 2006, Analytical chemistry.

[40]  Daniel Raftery,et al.  Design and construction of a microcoil NMR probe for the routine analysis of 20-μL samples , 2008 .

[41]  A. J. Shaka,et al.  Water Suppression That Works. Excitation Sculpting Using Arbitrary Wave-Forms and Pulsed-Field Gradients , 1995 .

[42]  M. Spraul,et al.  Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. , 2014, Analytical chemistry.

[43]  Daniel Raftery,et al.  Esophageal Cancer Metabolite Biomarkers Detected by LC-MS and NMR Methods , 2012, PloS one.

[44]  D. Wishart,et al.  Translational biomarker discovery in clinical metabolomics: an introductory tutorial , 2012, Metabolomics.

[45]  Michael A Kennedy,et al.  Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis , 2011, Arthritis research & therapy.

[46]  Eduard Y Chekmenev,et al.  Hyperpolarized (1)H NMR employing low gamma nucleus for spin polarization storage. , 2009, Journal of the American Chemical Society.

[47]  John L. Markley,et al.  Simultaneous Quantification and Identification of Individual Chemicals in Metabolite Mixtures by Two-Dimensional Extrapolated Time-Zero 1H−13C HSQC (HSQC0) , 2011, Journal of the American Chemical Society.

[48]  Daniel Raftery,et al.  Improved residual water suppression: WET180 , 2008, Journal of biomolecular NMR.

[49]  Cynthia K Larive,et al.  NMR spectroscopy for metabolomics and metabolic profiling. , 2015, Analytical chemistry.

[50]  Kazuo Shinozaki,et al.  Statistical indices for simultaneous large-scale metabolite detections for a single NMR spectrum. , 2010, Analytical chemistry.

[51]  Daniel Raftery,et al.  Design and construction of a versatile dual volume heteronuclear double resonance microcoil NMR probe. , 2009, Journal of magnetic resonance.

[52]  T. Bathen,et al.  High-resolution magic-angle-spinning NMR spectroscopy of intact tissue. , 2015, Methods in molecular biology.

[53]  Bowei Xi,et al.  NMR-based Metabolite Profiling of Pancreatic Cancer , 2015 .

[54]  Tanja Fehm,et al.  Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer , 2013, Molecular oncology.

[55]  Thomas Szyperski,et al.  Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe. , 2011, Journal of proteome research.

[56]  Richard L. Magin,et al.  High-Resolution Microcoil 1H-NMR for Mass-Limited, Nanoliter-Volume Samples , 1995, Science.

[57]  Ian D Wilson,et al.  Analytical strategies in metabonomics. , 2007, Journal of proteome research.

[58]  Daniel Raftery,et al.  Solvent signal as an NMR concentration reference. , 2008, Analytical chemistry.

[59]  Ian D. Wilson,et al.  1 H NMR and UPLC-MS E statistical heterospectroscopy: Characterization of drug metabolites (Xenometabolome) in epidemiological studies (Analytical Chemistry (2008) 80, (6835-6844)) , 2008 .

[60]  D. Raftery,et al.  Metabolomics-based methods for early disease diagnostics , 2008, Expert review of molecular diagnostics.

[61]  M. Mcphail,et al.  Biofluid metabonomics using 1H NMR spectroscopy: the road to biomarker discovery in gastroenterology and hepatology , 2012, Expert review of gastroenterology & hepatology.

[62]  B. McManus,et al.  The Human Serum Metabolome , 2011, PloS one.

[63]  Tetsuya Sakurai,et al.  PRIMe: A Web Site That Assembles Tools for Metabolomics and Transcriptomics , 2008, Silico Biol..

[64]  Daniel Raftery,et al.  15N-cholamine--a smart isotope tag for combining NMR- and MS-based metabolite profiling. , 2013, Analytical chemistry.

[65]  Daniel Raftery,et al.  RAMSY: ratio analysis of mass spectrometry to improve compound identification. , 2013, Analytical chemistry.

[66]  Daniel Raftery,et al.  A quick diagnostic test for NMR receiver gain compression , 2010, Magnetic resonance in chemistry : MRC.

[67]  G A Nagana Gowda,et al.  Biomarker Discovery and Translation in Metabolomics. , 2013, Current Metabolomics.

[68]  Rafael Brüschweiler,et al.  Metabolomics beyond spectroscopic databases: a combined MS/NMR strategy for the rapid identification of new metabolites in complex mixtures. , 2015, Analytical chemistry.

[69]  Rafael Brüschweiler,et al.  Quantitative analysis of metabolic mixtures by two-dimensional 13C constant-time TOCSY NMR spectroscopy. , 2013, Analytical chemistry.

[70]  D. Wishart,et al.  Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review , 2014, Metabolomics.

[71]  Maria De Iorio,et al.  Subset optimization by reference matching (STORM): an optimized statistical approach for recovery of metabolic biomarker structural information from 1H NMR spectra of biofluids. , 2012, Analytical chemistry.

[72]  R. Gerszten,et al.  Metabolomics and cardiovascular biomarker discovery. , 2012, Clinical chemistry.

[73]  Daniel Raftery,et al.  Application of 31P NMR spectroscopy and chemical derivatization for metabolite profiling of lipophilic compounds in human serum , 2009, Magnetic resonance in chemistry : MRC.

[74]  Daniel Raftery,et al.  Use of optimized 1D TOCSY NMR for improved quantitation and metabolomic analysis of biofluids , 2011, Journal of biomolecular NMR.

[75]  Daniel Raftery,et al.  Quantitating Metabolites in Protein Precipitated Serum Using NMR Spectroscopy , 2014, Analytical chemistry.

[76]  John L Markley,et al.  Metabolite identification via the Madison Metabolomics Consortium Database , 2008, Nature Biotechnology.

[77]  R. Brüschweiler,et al.  Covariance nuclear magnetic resonance spectroscopy. , 2004, The Journal of chemical physics.

[78]  John C Lindon,et al.  The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy. , 2002, Analytical biochemistry.

[79]  Daniel Raftery,et al.  Identification of 4-deoxythreonic acid present in human urine using HPLC and NMR techniques. , 2009, Journal of pharmaceutical and biomedical analysis.

[80]  Mattias Rantalainen,et al.  Statistical correlation and projection methods for improved information recovery from diffusion-edited NMR spectra of biological samples. , 2007, Analytical chemistry.

[81]  Robert Powers,et al.  The Current State of Drug Discovery and a Potential Role for NMR Metabolomics , 2014, Journal of medicinal chemistry.

[82]  Andrew N. Lane,et al.  The Handbook of Metabolomics , 2012, Methods in Pharmacology and Toxicology.

[83]  Bowei Xi,et al.  Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. , 2011, Analytica chimica acta.

[84]  Rafael Brüschweiler,et al.  Unified and Isomer-Specific NMR Metabolomics Database for the Accurate Analysis of 13C–1H HSQC Spectra , 2014, ACS chemical biology.

[85]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Daniel Raftery,et al.  Use of semiselective TOCSY and the pearson correlation for the metabonomic analysis of biofluid mixtures: application to urine. , 2005, Analytical chemistry.

[87]  Daniel Raftery,et al.  Chemoselective 15N tag for sensitive and high-resolution nuclear magnetic resonance profiling of the carboxyl-containing metabolome. , 2009, Analytical chemistry.

[88]  Ralf Tautenhahn,et al.  Toward 'omic scale metabolite profiling: a dual separation-mass spectrometry approach for coverage of lipid and central carbon metabolism. , 2013, Analytical chemistry.

[89]  Daniel Raftery,et al.  Ratio analysis nuclear magnetic resonance spectroscopy for selective metabolite identification in complex samples. , 2011, Analytical chemistry.

[90]  John C Lindon,et al.  The emergent role of metabolic phenotyping in dynamic patient stratification , 2014, Expert opinion on drug metabolism & toxicology.

[91]  Daniel Raftery,et al.  Quantitative analysis of blood plasma metabolites using isotope enhanced NMR methods. , 2010, Analytical chemistry.

[92]  Daniel Raftery,et al.  Nuclear Magnetic Resonance and Statistical Analysis , 2010 .

[93]  Burkhard Luy,et al.  Influence of Freezing and Storage Procedure on Human Urine Samples in NMR-Based Metabolomics , 2013, Metabolites.

[94]  Daniel Raftery,et al.  Pre-SAT180, a simple and effective method for residual water suppression. , 2008, Journal of magnetic resonance.

[95]  Aalim M Weljie,et al.  Targeted cancer therapeutics: biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors. , 2014, Current pharmaceutical design.

[96]  J. Chatham,et al.  Lactic acid and protein interactions: implications for the NMR visibility of lactate in biological systems. , 1999, Biochimica et biophysica acta.

[97]  Mattias Rantalainen,et al.  Analytic properties of statistical total correlation spectroscopy based information recovery in 1H NMR metabolic data sets. , 2009, Analytical chemistry.

[98]  David S. Wishart,et al.  MetaboMiner – semi-automated identification of metabolites from 2D NMR spectra of complex biofluids , 2008, BMC Bioinformatics.

[99]  Daniel Raftery,et al.  "Add to subtract": a simple method to remove complex background signals from the 1H nuclear magnetic resonance spectra of mixtures. , 2012, Analytical chemistry.

[100]  Daniel Raftery,et al.  Principal component analysis of urine metabolites detected by NMR and DESI–MS in patients with inborn errors of metabolism , 2007, Analytical and bioanalytical chemistry.

[101]  Elaine Holmes,et al.  Evaluation of high resolution magic-angle coil spinning NMR spectroscopy for metabolic profiling of nanoliter tissue biopsies. , 2012, Analytical chemistry.

[102]  Gregory S. Stupp,et al.  13C NMR Metabolomics: Applications at Natural Abundance , 2014, Analytical chemistry.

[103]  Teresa W.-M. Fan,et al.  Considerations of Sample Preparation for Metabolomics Investigation , 2012 .

[104]  Robert Powers,et al.  Combining DI-ESI–MS and NMR datasets for metabolic profiling , 2015, Metabolomics.

[105]  Jonathan V. Sweedler,et al.  High-Resolution NMR Spectroscopy of Sample Volumes from 1 nL to 10 μL , 1999 .

[106]  Neeraj Sinha,et al.  Quantification of metabolites from two-dimensional nuclear magnetic resonance spectroscopy: application to human urine samples. , 2009, Analytical chemistry.

[107]  Daniel Raftery,et al.  Receiver gain function: the actual NMR receiver gain , 2010, Magnetic resonance in chemistry : MRC.

[108]  Ian D Wilson,et al.  Global metabolic profiling for the study of alcohol-related disorders. , 2014, Bioanalysis.

[109]  Daniel Raftery,et al.  Ibuprofen metabolite profiling using a combination of SPE/column-trapping and HPLC-micro-coil NMR. , 2008, Journal of pharmaceutical and biomedical analysis.

[110]  D. Raftery,et al.  High-throughput nuclear magnetic resonance analysis using a multiple coil flow probe. , 2003, Analytical chemistry.

[111]  Jeremy K. Nicholson,et al.  Statistical HOmogeneous Cluster SpectroscopY (SHOCSY): An Optimized Statistical Approach for Clustering of 1H NMR Spectral Data to Reduce Interference and Enhance Robust Biomarkers Selection , 2014, Analytical chemistry.

[112]  Daniel Raftery,et al.  Advances in NMR-Based Metabolomics , 2014 .

[113]  Rafael Brüschweiler,et al.  High-resolution homonuclear 2D NMR of carbon-13 enriched metabolites and their mixtures. , 2012, Journal of magnetic resonance.

[114]  Robert S Plumb,et al.  Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. , 2006, Analytical chemistry.

[115]  Lucio Frydman,et al.  Ultrafast two-dimensional nuclear magnetic resonance spectroscopy of hyperpolarized solutions , 2007 .

[116]  Daniel Raftery,et al.  Saturation transfer double‐difference NMR spectroscopy using a dual solenoid microcoil difference probe , 2008, Magnetic resonance in chemistry : MRC.

[117]  Daniel Raftery,et al.  Differentiating Hepatocellular Carcinoma from Hepatitis C Using Metabolite Profiling , 2012, Metabolites.